hábit Labs · Devolve Corp
Certificate of Analysis
FOR RESEARCH PURPOSES ONLY. This material is supplied for in-vitro laboratory research by qualified researchers. It shall not be used for human therapeutic purposes and is not for human or veterinary consumption. It is not a drug, supplement, cosmetic, food additive, or medical device.
Product identification
ProductCJC + IPA 10mg
DescriptionGHRH analog + GH secretagogue blend
Lot numberCIB-2607-P
Release dateJul 2026
Molecular formulaTwo-peptide blend
AppearanceLyophilized powder
Storage−20 °C, protected from light
ManufacturerDevolve Corp d/b/a hábit · Ft. Lauderdale, FL
Analytical results
CJC-1295 identityConfirmed✓ Pass
CJC-1295 purity99.2%✓ Pass
Ipamorelin identityConfirmed✓ Pass
Ipamorelin purity99.3%✓ Pass
Endotoxin (LAL)<0.5 EU/mg✓ Pass
AppearanceWhite cake✓ Pass
Each component named, weighed, identified by LC-MS, purity by HPLC, endotoxin assayed. Third-party ISO-17025 verification on the finished blend and each component.
Specifications
CompositionCJC-1295 (no DAC) + ipamorelin
FormLyophilized, sealed under nitrogen
Purity≥99% per component by HPLC
Endotoxin<0.5 EU/mg
Vial mass10mg blend
Lot prefixCIB-
Storage & handling
Lyophilized: −20°C, 24 months. Reconstituted: 2–8°C, use within 21 days. Reconstitute with bacteriostatic water; swirl gently, do not shake.